Ciprofloxacin and doxycycline 2022-2023
key details
| Value | £1 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 31 Aug 2021 |
| Contract start | 1 Apr 2022 |
| Contract end | 31 Mar 2023 |
| Procedure | selective |
| SME suitable | Yes |
| OCID | ocds-b5fd17-b6fe1cec-21b6-4283-8ab1-c523bb136698 |
Awards (3)
This procurement was awarded to 3 suppliers. Values shown are per-award; the notice total is £1.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd | £1 | 30 Dec 2021 | active |
| Bayer Plc | £1 | 30 Dec 2021 | active |
| Kent Pharma Ltd | £1 | 26 Jan 2022 | active |
description
A specific procurement under a dynamic purchasing system ref CM/EMP/21/21025 for the supply of antidotes and antibiotics, for the provision of ciprofloxacin suspension/iv and doxycycline capsules.
The contract value is withheld from publication as the authority has deemed that its release would be contrary to the public interest.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 10 Feb 2022 | Award (award) | · | d3022c9e-76b5-41bd-85bf-2a8426fb0a12-508889 |
| 10 Feb 2022 | Award (award) | · | 10db7699-8fd4-4c68-a867-655b4fcbdee9-508891 |
| 10 Feb 2022 | Award (award) | · | 71b911df-9e25-48db-9e08-3ec33466c7c3-508892 |
more from Secretary of State for Health and Social Care acting as part of the Crown through the UK Health Security Agency
- RSV immunisations (2024) · 24 Jan 2024
- Pralidoxime chloride 2024 · 22 Nov 2023
- Agreement for the reservation of manufacturing capacity and production and supply of influenza pandemic specific vaccine during a pandemic. · £1 · 2 Oct 2023
- Pneumococcal conjugate vaccine (PCV) 2024 · 27 Jul 2023
- Tuberculin purified protein derivative (PPD) 2024 · 2 Mar 2023
- DTaP/IPV 2024 · 11 Jan 2023
- Advanced Purchase Agreement for Pandemic Specific Vaccines · 23 Aug 2022
- BCG 2023 · 6 Jul 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.